Results 41 to 50 of about 60,113 (237)

Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery. a systematic review and meta-analysis [PDF]

open access: yes, 2017
Background: Previous studies have shown beneficial effects of levosimendan in high-risk patients undergoing cardiac surgery. Two large randomized controlled trials (RCTs), however, showed no advantages of levosimendan.
Arcadipane, Antonio   +8 more
core   +2 more sources

Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial

open access: yesCritical Care, 2018
BackgroundLow cardiac output syndrome (LCOS) is a severe condition which can occur after cardiac surgery, especially among patients with pre-existing left ventricular dysfunction. Dobutamine, its first-line treatment, is associated with sinus tachycardia.
L. Nguyen   +8 more
semanticscholar   +1 more source

The effects on arterial haemoglobin oxygen saturation and on shunt of increasing cardiac output with dopamine or dobutamine during one-lung ventilation [PDF]

open access: yes, 2004
Publisher's copy made available with the permission of the publisher © Australian Society of AnaesthetistsTheoretically, if the cardiac output were increased in the presence of a given intrapulmonary shunt, the arterial saturation should improve as the ...
Furman W.R.   +4 more
core   +2 more sources

Levosimendan in Sepsis. [PDF]

open access: yes, 2017
Commentum to "Levosimendan for the Prevention of Acute Organ Dysfunction in ...
Morelli, Andrea, Tritapepe, Luigi
core   +1 more source

Evaluation of the anti-ischemic effects of D-ribose during dobutamine stress echocardiography: a pilot study

open access: yesCardiovascular Ultrasound, 2009
D-Ribose, a pentose sugar, has shown to improve myocardial high-energy phosphate stores depleted by ischemia. This study investigated the ability of D-Ribose with low dose dobutamine to improve the contractile response of viable myocardium to dobutamine ...
Gradus-Pizlo Irmina   +6 more
doaj   +1 more source

Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial

open access: yesMedical Science Monitor, 2016
Background We aimed to investigate the effect of levosimendan on biomarkers of myocardial injury and systemic hemodynamics in patients with septic shock.
Jianbiao Meng   +6 more
semanticscholar   +1 more source

Levosimendan for the prevention of acute organ dysfunction in sepsis [PDF]

open access: yes, 2016
BACKGROUND Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may improve outcomes in patients with sepsis. METHODS We conducted a double-blind, randomized clinical trial to investigate whether levosimendan reduces the ...
Al-Beidh, F   +16 more
core   +2 more sources

Characterizing cardiac involvement in chronic kidney disease using CMR—a systematic review [PDF]

open access: yes, 2018
Purpose of Review: The aim of the review was to identify and describe recent advances (over the last 3 years) in cardiac magnetic resonance (CMR) imaging in patients with chronic kidney disease (CKD).
Mangion, Kenneth   +3 more
core   +1 more source

Dobutamine-induced strain and strain rate predict viability following fibrinolytic therapy in patients with ST-elevation myocardial infarction

open access: yesFrontiers in Cardiovascular Medicine, 2015
Background: Low-dose dobutamine stress echocardiography is increasingly used for identifying myocardial viability.Aim: We explored whether dobutamine-induced strain (S) and strain rate (SR) can identify myocardial viability following fibrinolytic therapy
Mohamed eIsmail, Wail eNammas
doaj   +1 more source

Antitumor activity of dobutamine on human osteosarcoma cells

open access: yesOncology Letters, 2016
Dobutamine has been widely used for the treatment of heart failure and cardiogenic shock since the 1970s. Osteosarcoma is the most commonly observed malignant bone tumor in children.
Jun Yin   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy